Welcome to LookChem.com Sign In|Join Free

CAS

  • or

74220-43-2

Post Buying Request

74220-43-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • Pregna-4,9(11)-diene-3,20-dione,21-(acetyloxy)-16,17-dihydroxy-, (16a)- (9CI)

    Cas No: 74220-43-2

  • USD $ 1.0-1.0 / Metric Ton

  • 1 Metric Ton

  • 100 Metric Ton/Day

  • Bluecrystal chem-union
  • Contact Supplier

74220-43-2 Usage

Chemical structure

A synthetic steroid hormone derived from progesterone.

Parent compound

Prednisolone, a corticosteroid with anti-inflammatory and immunosuppressant properties.

Anti-inflammatory effects

Similar to prednisolone, it reduces inflammation by inhibiting the production of inflammatory mediators.

Immunosuppressive effects

Suppresses the immune response, making it useful for treating autoimmune conditions.

Medical uses

Treatment of various inflammatory and autoimmune conditions, such as rheumatoid arthritis, asthma, and allergic reactions.

Administration

Typically administered orally or via injection.

Combination therapy

May be used in combination with other medications to achieve the desired therapeutic effect.

Mechanism of action

Inhibits the production of inflammatory mediators and suppresses the immune response.

Molecular weight

400.5 g/mol

Appearance

White to off-white crystalline powder

Solubility

Soluble in most organic solvents, slightly soluble in water.

Stability

Stable under normal temperature and pressure, should be stored in a cool, dry place, and protected from light and moisture.

Safety precautions

Not to be used in patients with a known hypersensitivity to the drug or its components. Long-term use may result in side effects such as weight gain, fluid retention, and increased risk of infection.

Drug classification

Corticosteroid

Pregnancy and lactation

Category C, should be used during pregnancy and lactation only if the potential benefit justifies the potential risk to the fetus or infant.

Drug interactions

May interact with other medications, including other corticosteroids, immunosuppressants, and live vaccines.

Side effects

Common side effects include fluid retention, increased appetite, weight gain, and mood changes. More serious side effects may include adrenal suppression, osteoporosis, and increased risk of infection.

Check Digit Verification of cas no

The CAS Registry Mumber 74220-43-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,4,2,2 and 0 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 74220-43:
(7*7)+(6*4)+(5*2)+(4*2)+(3*0)+(2*4)+(1*3)=102
102 % 10 = 2
So 74220-43-2 is a valid CAS Registry Number.

74220-43-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name [2-[(8S,10S,13S,14S,16R,17S)-16,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate

1.2 Other means of identification

Product number -
Other names EINECS 277-774-3

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:74220-43-2 SDS

74220-43-2Relevant articles and documents

-

Bernstein et al.

, p. 1696,1699 (1959)

-

Preparation process of halcinonide intermediate

-

Paragraph 0008; 0009, (2017/07/19)

The invention provides a prepration process of a halcinonide intermediate. The preparation process comprises the steps: taking a hydrofluoric acid-acetone mixed solvent as a solvent, slowly adding an intermediate N-3 at subzero 40 DEG C to subzero 30 DEG C, carrying out reaction for 4 to 8 hours after material feeding is completed, enabling the temperature to return to subzero 5 DEG C to 0 DEG C, continuously carrying out reaction for 10 to 30 min, slowly adding reaction fluid into a potassium carbonate solution after the reaction is completed, adjusting the PH value to 7.0 to 7.5, filtering and discharging a product, and drying the product to obtain the halcinonide intermediate with the structure as shown in formula N-5. According to the preparation process, a one-pot method is adopted for production, so that the production steps are effectively simplified, and the production period is shortened; the preparation process is more environment-friendly.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 74220-43-2